MWX Mineworx Technologies Ltd

Medworxx Solutions Inc. (the "Company")(TSX VENTURE:MWX) announced today it has
filed with the Canadian securities authorities its year end consolidated
financial statements and management discussion & analysis report for year ended
December 31, 2010. These documents may be viewed under the Company's profile at
www.sedar.com. 


Q4 and Fiscal 2009 Highlights:



--  Revenue for the year ended December 31, 2009 was $4,088,625 as compared
    to $3,348,842 for the previous year, a 22% increase for the year. 
    
--  The fourth quarter of 2009 was the first EBITDA positive quarter for the
    Company. EBITDA is defined as Earnings before Interest, Taxes,
    Depreciation, and Amortization. EBITDA for the year was ($465,789) as
    compared to EBITDA in the prior year of ($1,532,748) an improvement of
    $1,066,959. Adjusted EBITDA (Earnings before Interest, Taxes,
    Depreciation, Amortization, and Stock Option Expense) for the year was
    ($216,093) as compared to ($1,324,057) in the prior year, an improvement
    of $1,107,964. EBITDA and Adjusted EBITDA are non-GAAP (Generally
    Accepted Accounting Principles) measures. 
    
--  Total expenses before loss/gain on foreign exchange, SR&ED expense, and
    interest on long-term debt for 2009 were $4,634,305, representing a
    decrease of 8% from expenses of $5,036,968 in the prior year. These
    numbers reflect Management's planned control of expenses as Medworxx
    drives to profitability. 
    
--  Contract value of recurring revenue at December 31, 2009 with existing
    customers was $3,199,000 as compared to $2,656,000 at December 31, 2008,
    representing a 20% increase year over year. The Company defines contract
    value of recurring revenue as the contract value or agreement amount for
    the annual renewable agreements which at the end of a reporting period
    management believes there to be a high probability of renewal. As the
    full value of such contracts is recognized as revenue over 12 months,
    the growth in this value is an important metric for the Company. This is
    a non-GAAP measure. 
    
--  Revenue from consulting services increased to $697,308 in 2009 from
    $555,148 in 2008, representing a 26% increase. This increase is
    attributable to growth in the customer base, and more of a focus on
    services work and custom development for hospitals. 
    
--  The Company incurred losses of $650,842 on revenue of $4,088,625 for the
    year ended December 31, 2009 versus losses of $1,649,688 incurred for
    the prior year on revenue of $3,348,842. This represents a $998,840
    decrease in the annual loss. This improvement in results of operations
    is due to the Company's focus on getting to profitability, growing
    revenue and tightly controlling expenses. 
    
--  The Company completed a $410,000 aggregate principal amount private
    placement of convertible debentures maturing on February 20, 2011. 
    
--  The Company announced a new independent assessment platform that will
    enhance support of the new standardized Ontario Alternate Level of Care
    (ALC) definition. Management believes there is a strong market for this
    new solution because it is being mandated in Ontario and similar
    initiatives are occurring across Canada. 
    
--  The Company surpassed the 100 customer mark in the second quarter, and
    finished the year with 120 customers (representing over 300 hospitals)
    in North America including hospitals throughout Canada and 17 states in
    the USA. This represents a significant milestone in the Company's
    growth. 
    
--  The Company announced, along with partner Everbridge (formerly 3n) that
    their integrated advanced incident command solution (ICS) for hospitals
    has been adopted throughout significant portions of Regions 2 and 3 of
    the Florida Regional Domestic Security Task Forces to improve emergency
    preparedness and response. The 7 hospitals adopting the Medworxx
    Emergency Readiness System represent 15,000 employees. These projects
    were funded by ASPR (Office of the Assistant Secretary for Preparedness
    and Response) grants. The ASPR is the principal advisor to the Secretary
    on matters relating to public health and medical emergencies, whether
    resulting from acts of nature, accidents, or terrorism. Management
    believes that these implementations will provide a strong foundation on
    which to grow additional ERS business. 
    
--  Sonic Healthcare USA (Sonic) licensed the Medworxx Learning Management
    System. Sonic's US operation includes six independent regional medical
    laboratories, that provide physicians with the highest quality
    laboratory testing, delivered with personalized service, catering to the
    individual needs of the local medical community. This contract is
    significant to Medworxx as it demonstrates the Company's ability to
    expand outside of hospitals to other healthcare organizations. 
    
--  The Company signed its first Quebec customer, CSSS (Centre for Health
    and Social Services) du Lac-des-Deux-Montagnes. CSSS will implement the
    Medworxx Clinical Utilization Management System (UMS), known in the
    Quebec marketplace as Med-Clinique. Medworxx' strategic partner for
    Quebec, MediaMed Technologies, was instrumental in the sale of the
    system and will work with CSSS to implement the solution. Management
    believes that there is tremendous need for this application in Quebec. 
    
--  St. Thomas Elgin Hospital (STEGH) licensed and went "live" with the
    Medworxx Bed Optimization System, to help streamline their Bed
    Management. They are the first hospital to roll out this product which
    is a new addition to the Medworxx Patient Flow Platform. 
    
--  The Company announced that every hospital within the Erie St. Clair
    Local Health Integration Network (LHIN) is a Medworxx customer with the
    licensing of the Medworxx Learning Management System and Policy and
    Document Management System at Bluewater Health. This further
    demonstrates the Company's ability to provide solutions on a larger
    scale versus exclusively for individual hospitals. 
    
--  The Shared Service Organization representing British Columbia Health
    Authorities licensed two elements of the Medworxx Patient Flow Platform.
    Fraser Health Authority will be the first health authority in BC to use
    the Medworxx Utilization Management System (UMS) and Independent
    Assessment Platform for their acute care program. The contract is
    expected to bring over $1.1 million in revenue to Medworxx over 5 years.
    The nine largest hospitals in the Fraser Health Authority will be using
    Medworxx, monitoring 1,750 beds. 
    



"We are happy to be able to report our first EBITDA positive quarter for the
fourth quarter of Fiscal 2009", said Dan Matlow, President & CEO, Medworxx. "The
Medworxx team continues to focus on execution of our business plan; the Company
grew 22% in 2009. We are effectively growing our revenue and our customer base,
while controlling expenses."


ABOUT MEDWORXX

Medworxx is a Toronto-based software company focused exclusively on solutions
for the North American healthcare marketplace. Medworxx provides healthcare
solutions for patient flow, compliance and education. Its software comprises an
integrated suite of solutions, including content management, learning
management, policies and procedures, utilization management, bed optimization,
single sign on, portal, and emergency readiness solutions.


Medworxx started business in May 2004 in Ontario with 3 employees and has since
grown to over 35 employees. Medworxx' executive team consists of experienced
sales, marketing, software development, healthcare, and finance personnel.
Medworxx currently has a customer base of approximately 100 healthcare
organizations representing more than 300 hospitals and 500,000 end users who are
distributed approximately 70% in Canada and 30% in the United States. Medworxx'
customers use its software platform to increase competency, reduce redundancy,
reduce costs, and simplify distribution of knowledge to staff and patients,
creating a net effect of increased efficiency and improved patient safety and
care.


Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. Often, but not always,
forward-looking statements can be identified by the use of words such as
"plans", "expects" or "does not expect", "is expected", "estimates", "intends",
"anticipates" or "does not anticipate", or "believes", or variations of such
words and phrases or state that certain actions, events or results "may",
"could", "would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks, uncertainties and
other factors, such as competition, technological changes, the changing needs of
hospitals, the financial condition of the Company's current and potential
customers, foreign currency exchange rates, as well as general economic
conditions, which may cause the actual results, performance or achievements of
the Corporation and Medworxx to be materially different from any future results,
performance or achievements

expressed or implied by the forward-looking statements. Actual results and
developments are likely to differ, and may differ materially, from those
expressed or implied by the forward-looking statements contained in this press
release. There can be no assurance that forward-looking statements will prove to
be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place
undue reliance on forward-looking statements.

Mineworx Technologies (TSXV:MWX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024

Mineworx Technologies (TSXV:MWX)
Gráfica de Acción Histórica
De May 2023 a May 2024